A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A

← catalyst calendar

NCT05685238 · readout in 681 d

Sponsored by Novo Nordisk A/S (industry) · NVO — their whole pipeline →.

Phase

Phase 3

Status

Recruiting

Study type

Interventional

Design

Non randomized · None · Treatment

Enrollment

451estimated

Sites

152

Countries

Austria, Belgium, Bulgaria +29

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis

Date

Filed

Basis

What it is

Start

2023-02-13

actual

When the study began enrolling

Primary completion

2028-06-30

estimated

The date the last participant is measured for the primary outcome — the readout window

Study completion

2028-06-30

estimated

The whole study's end, after follow-up

First posted

2023-01-17

actual

When this record first appeared on the registry

Results posted

—

When the sponsor posted results to the registry

Record updated

2026-06-30

actual

The sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

Haemophilia A
Haemophilia A With Inhibitors

Intervention

Drug: Mim8

Primary outcomes

what the primary-completion date above is the date OF

Arm 1 and 2: Number of treatment emergent adverse events

measured From week 0 until end of study (up to 283 weeks)

Arm 3: Number of treatment emergent adverse events

measured From treatment initiation (week 0) until end of study (up to 124 weeks)

Publications

PMID 42469164 — linked by the registry

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · NVO's whole pipeline · Catalyst calendar · Every registered study · What changed